Abstract
Aim: Advances in circulating tumor DNA (ctDNA) analysis for diffuse large B-cell lymphoma (DLBCL) have prompted the evaluation of its utility in other non-Hodgkin lymphomas (NHLs), leading to significant insights into its potential applications.
Funding Information
  • National Natural Science Foundation of China (82300151)
  • Xinrui Tumor Support Therapy Project Fund (FB2024012256)
  • National Health Commission Medical and Health Science and Technology Development Research Center Post-Marketing Clinical Research Special Project for Innovative Drugs (WKZX2023CX020008)

This publication has 43 references indexed in Scilit: